Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2020

Kudo Y, Sugimoto M, Arias E, Kasashima H, Cordes T, Linares JF, et al. PKCλ/ι Loss Induces Autophagy, Oxidative Phosphorylation, and NRF2 to Promote Liver Cancer Progression. Cancer Cell. 2020;38(2):247-262.e11.

Humphries RM, Magnano P, Burnham CA, Bard JD, Dingle TC, Callan K, et al. Evaluation of Surrogate Tests for the Presence of -Mediated Methicillin Resistance in Staphylococcus capitis, Staphylococcus haemolyticus, Staphylococcus hominis, and Staphylococcus warneri. J Clin Microbiol. 2020;59(1).

Nakamichi K, Shen JZ, Lee CS, Lee AY, Roberts EA, Simonson PD, et al. Outcomes associated with SARS-CoV-2 viral clades in COVID-19. medRxiv. 2020.

Kim J-, Lin C, Stavre Z, Greenblatt MB, Shim J-. Osteoblast-Osteoclast Communication and Bone Homeostasis. Cells. 2020;9(9).

Sun J, Feng H, Xing W, Han Y, Suo J, Yallowitz AR, et al. Histone demethylase LSD1 is critical for endochondral ossification during bone fracture healing. Sci Adv. 2020;6(45).

Goyal A, Ellenson LH, Pirog EC. p16 Positive Histologically Bland Squamous Metaplasia of the Cervix: What does It Signify? Am J Surg Pathol. 2020;44(1):129-139.

Haney NM, Faisal FA, Lu J, Guedes LB, Reuter VE, Scher HI, et al. Loss with Negative Status is Associated with Lethal Disease after Radical Prostatectomy. J Urol. 2020;203(2):344-350.

Sangiorgio VF, Geyer JT, Margolskee E, Al-Kawaaz M, Mathew S, Tam W, et al. Myeloid neoplasms with isolated del(5q) and V617F mutation: a "grey zone" combination of myelodysplastic and myeloproliferative features? Haematologica. 2020;105(6):e276-e279.

Satlin MJ, Goyal P, Magleby R, Maldarelli GA, Pham K, Kondo M, et al. Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease. PLoS One. 2020;15(7):e0236778.

Armache A, Yang S, de Paz AM, Robbins LE, Durmaz C, Cheong JQ, et al. Histone H3.3 phosphorylation amplifies stimulation-induced transcription. Nature. 2020;583(7818):852-857.